A class of therapies called PDE4 inhibitors, which are approved to manage certain inflammatory diseases, may help boost the functionality…
Articles by Marisa Wexler, MS
In babies with cystic fibrosis (CF), the types of bacteria living in the upper airway become more diverse during…
Images taken via an ultrasound of the liver can be used to identify children with cystic fibrosis (CF) who…
Variations in levels of certain regulatory RNA molecules in immune cells may help to explain why women and girls with…
30 Technology has sold the rights to its antimicrobial treatment platform for certain uses, such as for burns and…
Women with cystic fibrosis (CF) are motivated to work with their healthcare providers to make decisions about their reproductive…
As pregnancy becomes more common among women with cystic fibrosis (CF), and more CF patients are becoming parents, there…
Health Canada has extended its approval of Orkambi (lumacaftor/ivacaftor) to treat children as young as 1…
In a small clinical trial, Orkambi (lumacaftor/ivacaftor) appeared to reduce structural damage in the lungs, as measured by a…
Packets of molecular cargo called extracellular vesicles (EVs) can be isolated from the blood of people with cystic fibrosis…